TTS Call for Nominations - TTS Vice President
With his selection as the new Editor-in-Chief of Transplantation Journals (starting January 1, 2025), Stefan Tullius has decided to step down as TTS Vice President. Consequently, we will be holding a by-election for the position of TTS Vice President for a period of two years. To be eligible to run, applicants must have served on the council for a complete term. Our staff will send an email notification to all members who are eligible to run for the position. If you are unsure of your eligibility, please email membership@tts.org.
Nomination Deadline: June 14, 2024
In case your missed it, see the TTS 2024 Election Results
Just Released - Transplantation Journal - June Issue
The June issue of Transplantation Directjam-packed with articles on a wide-variety of topics affecting different transplanted organs including kidney, liver, heart, pancreas, intestine, multi-organ, VCA, and others. Just to name a few themes, infectious disease topics are covered related to CMV, EBV, HIV, hepatitis E and cryptococcus, as well as COVID vaccination. There are overviews on the urobiome, left ventricular hypertrophy in kidney transplantation and the use of cytopheric devices for pre-transplant bridging. Machine perfusion studies are represented, and also various studies on surgical aspects of transplantation related to intestinal/multi-organ surgeries, new techniques in HCC liver transplant recipients, and an assessment of surgical complications after kidney transplantation. Organ donation topics include articles on organ underutilization, live donor mental health, variations in DCD liver transplant protocols in the U.S., improved treatments of uDCD kidneys for transplantation, and organ access for small recipients. This is just a sampling of topics to highlight, so please visit our open-access Transplantation Direct website for full details of these and other articles of interest.
Table of Contents
Commentary
Kidney Transplantation
- The Role of the Urobiome in Kidney Transplantation: A Systematic Review
- Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine Booster Doses in Kidney Transplant Recipients: Results of a 12-mo Follow-up From a Prospective Observational Study
- Surgical Complications Following Renal Transplantation in a Large Institutional Cohort
- Expanding Access to High KDPI Kidney Transplant for Recipients Aged 60 y and Older: Cost Utility and Survival
- Cytomegalovirus Matching in Deceased Donor Kidney Allocation: Results From a U.S. National Simulation Model
- Long-term Safety in Epstein–Barr Virus–Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final Study Results From the ENLiST Registry
- Preoperative Risk Assessment of Early Kidney Graft Loss
- Left Ventricular Hypertrophy After Renal Transplantation: Systematic Review and Meta-analysis
- Absence of IL-6 Receptor Blockade Effect on the Outcomes of Transplant Glomerulopathy in the Absence of Anti-HLA Donor-specific Antibodies
- Management and Outcomes of Kidney Transplant Candidates With Severe Pulmonary Hypertension: A Single-center Strategy and Experience
- Multiple-target Therapy for Posttransplant Focal Segmental Glomerulosclerosis
Liver Transpantation
- Normothermic Machine Perfusion Reduces Transfusion Requirements Even After Static Cold Storage: A 1 y Retrospective Single-center Analysis
- “No-Touch” Left Approach for Recipient Hepatectomy: A Promising Strategy to Minimize Hepatocellular Carcinoma Recurrence in Liver Transplantation
- A Decade of Liver Transplantation in the United States: Drivers of Discard and Underutilization
- Evaluating the Correlation Between Anteroposterior Diameter, Body Surface Area, and Height for Liver Transplant Donors and Recipients
- Differential Effects of Ascites and Hepatic Encephalopathy on Waitlist Mortality in Liver Transplantation by MELD 3.0
- Four-factor Prothrombin Complex Concentrate During Liver Transplantation: A Retrospective Cohort Study
- Variation in DCD Liver Transplant Protocols Among Transplant Centers in the United States
Intestinal Transplantation
Hand and Composite Tissue Allotransplantation
Pancreas and Islet Transplantation
Organ Donation and Procurement
- A Contemporary Analysis of Mental Well-being Among Living Donor Kidney Applicants
- Subnormothermic Oxygenated Machine Perfusion (24 h) in DCD Kidney Transplantation
- Prophylactic Anticoagulation Reduces the Risk of Kidney Graft Venous Thrombosis in Recipients From Uncontrolled Donation After Circulatory Death Donors With High Renal Resistive Index
- Deceased Donors With HIV in the Era of the HOPE Act: Referrals and Procurement
Infectious Disease
- Hepatitis E Virus Infection in a Pregnant Liver Transplant Recipient Leading to Chronic Infection
- Less Is More? Two Cases of Cryptococcosis Treated Using Single-dose Liposomal Amphotericin B as Part of Induction Therapy in Solid Organ Transplant Recipients
Cell Therapy
TTS 2025 Newsletter #5 - May 30
Congress Receives CVS Compliance
We are proud to announce that the TTS 2024 Congress has been recognized as compliant by the Conference Vetting System (CVS) and e4ethics. This recognition underscores our commitment to transparency and ethical standards in medical education.
TTS @ATC2024 - Philadelphia, USA - June 1-5, 2024
Pictured from left to right: Jennifer Groverman (Manager, DICG & Projects) Marcelle McPhaden (TTS Executive Director) and Marcelo Cantarovich (TTS Immediate Past President)
CAST 2023 - Hong Kong Recordings
5th Summit on Stem Cell Derived Islets - Call for Abstracts
On behalf of the International Pancreas and Islet Transplant Association (IPITA), the Harvard Stem Cell Institute (HSCI) and Juvenile Diabetes Research Foundation (JDRF), we are pleased to announce the 5th Summit on Stem Cell Derived Islets to be held at the Joseph B. Martin Conference Center in Boston, MA, USA from October 28-29, 2024. Visit www.stemcellislet.ipita.org for complete Summit details and to register today!
Abstract Submission Deadline:
June 15, 2024
Transplantation Journal Highlights
Transplantation - Social Media Content
Gas6/AXL Alleviates Hepatic Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via the PI3K/AKT Pathway
Hepatic ischemia/reperfusion (I/R) injury is a major cause of complications in clinical liver surgery. AXL receptor tyrosine kinase (AXL) is a member of the TAM receptor tyrosine kinase family (TYRO3, AXL, and MERTK). Our previous study has shown that AXL expression was markedly upregulated in liver transplantation patients. However, the underlying mechanism of AXL in hepatic I/R injury remains unclear.
Targeted Restoration of GPX3 Attenuates Renal Ischemia/Reperfusion Injury by Balancing Selenoprotein Expression and Inhibiting ROS-mediated Mitochondrial Apoptosis
Renal ischemia/reperfusion (IR) injury is the leading cause of acute kidney injury in both autologous and transplanted kidneys. Low-level glutathione peroxidase 3 (GPX3) is associated with renal IR injury. The exact mechanism of targeted GPX3 restoration in renal IR injury has yet to be determined.
Transplantation Direct - Social Media Content
National Trends in Utilization of Normothermic Machine Perfusion in DCD Liver Transplantation
In liver transplantation, advances in ex situ normothermic machine perfusion (NMP) have improved outcomes compared with traditional static cold storage (SCS) in donation after circulatory death (DCD) organs. We aimed to characterize trends in the utilization of NMP versus SCS in DCD liver transplantation in the United States.
Reanimating Pancreatic Grafts Subjected to Prolonged Cold Ischemic Injury Using Normothermic Ex Vivo Perfusion
Pancreas transplant volumes are limited because of poor utilization of “extended criteria grafts.” Prolonged cold ischemia is a risk factor associated with poor allograft survival. We aimed to establish the feasibility of transplantation using grafts subjected to prolonged cold ischemia and determine whether these grafts could be optimized using normothermic ex vivo perfusion (NEVP) in a porcine model.
TID - Quality and Safety Survey
TID has launched a survey to develop quality indicators for managing infections in transplantation, aiming to improve patient outcomes. They seek input from centers worldwide to understand their data and mechanisms for handling post-transplant infections. This will enable collaboration with international organizations to create robust indicators. Only one representative per center is needed, preferably with an administrator. Your participation is crucial for advancing the field of Transplant Infectious Disease. Thank you for your contribution!
Contact
Address
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada